IndraLab

Statements


| 2

reach
"Sulfonylurea-related compounds seem to block inflammasome activation somewhat upstream of NLRP3, but not by direct interaction with the NLRP3 protein [32] ."

reach
"Sulfonylurea drugs seem to specifically inhibit the triggering step of NLRP3 activation without affecting the NF-kappaB signaling related priming step or the activation of other inflammasomes XREF_BIBR, XREF_BIBR."